​Coronary ​Heart Disease Models 

Latest Release: 14.10.2018

Latest Version: PROSIT Coronary Heart Disease Model 2018B Germany - Release Candidate

Summary: New release of the cardiovascular disease model based on a similar methodology as Missouri A that allows to include patient sub-groups.

Methodology: Markov model (Markov process)

Health Economic Perspective: flexible, dependent on user specification

Time Horizon: 80 cycles; currently defined as annual time steps

Patient Cohort: realistic diabetes cohort for Germany and type 2 diabetes mellitus based on the ProValue study. Divided into up to 16 sub-cohorts. Cohort specifications can be edited freely. 

Costs: summary costs for Germany are included based on the KODIM Cost study and results being inflationed to the year 2015. Costs can be edited freely. 

Other specifications: the model supports QALYS, and discounting of both costs and effects. The half-cycle correction is implemented as within-cycle correction.

Team Members: Fabian Sailer, Monika Pobiruchin, Wendelin Schramm

Previous Versions: PROSIT CHD Type 2 Diabetes Disease Model 2016B Germany (from 28. September 2017)